期刊文献+

Saposin C stimulates growth and invasion,activates p42/44 and SAPK/JNK signaling pathways of MAPK and upregulates uPA/uPAR expression in prostate cancer and stromal cells 被引量:7

Saposin C stimulates growth and invasion,activates p42/44 and SAPK/JNK signaling pathways of MAPK and upregulates uPA/uPAR expression in prostate cancer and stromal cells
下载PDF
导出
摘要 Aim:To determine the effect of saposin C (a known trophic domain of prosaposin) on proliferation,migration and invasion,as well as its effect on the expression of urokinase plasmonogen activator (uPA),its receptor (uPAR) and matrix metalloproteinases (MMP)-2 and -9 in normal and malignant prostate cells.In addition,we tested whether saposin C can activate p42/44 and stress-activated protein kinase/c-Jun NH_2-terminal kinase (SAPK/JNK) signal transduction pathways of the mitogen-activated protein kinase (MAPK) superfamily.Methods:We employed West- ern blot analysis,phospho-specific antibodies,cell proliferation assay,reverse transcriptase-polymerase chain reaction, in vitro kinase assays and migration and invasion to determine the effect of saposin C on various biological behaviors of prostate stromal and cancer cells.Results:Saposin C,in a cell type-specific manner,upregulates uPA/uPAR and immediate early gene c-Jun expression,stimulates cell proliferation,migration and invasion and activates p42/44 and SAPK/JNK MAPK pathways in prostate stromal and cancer cells.Normal prostate epithelial cells were not responsive to saposin C treatment in the above studies.Conclusion:Saposin C functions as a multipotential modulator of diverse biological activities in prostate cancer and stromal cells.These results strongly suggest that saposin C functions as a potent growth factor for prostatic cells and may contribute to prostate carcinogenesis and/or the development of hormone-refractory prostate cancer. Aim:To determine the effect of saposin C (a known trophic domain of prosaposin) on proliferation,migration and invasion,as well as its effect on the expression of urokinase plasmonogen activator (uPA),its receptor (uPAR) and matrix metalloproteinases (MMP)-2 and -9 in normal and malignant prostate cells.In addition,we tested whether saposin C can activate p42/44 and stress-activated protein kinase/c-Jun NH_2-terminal kinase (SAPK/JNK) signal transduction pathways of the mitogen-activated protein kinase (MAPK) superfamily.Methods:We employed West- ern blot analysis,phospho-specific antibodies,cell proliferation assay,reverse transcriptase-polymerase chain reaction, in vitro kinase assays and migration and invasion to determine the effect of saposin C on various biological behaviors of prostate stromal and cancer cells.Results:Saposin C,in a cell type-specific manner,upregulates uPA/uPAR and immediate early gene c-Jun expression,stimulates cell proliferation,migration and invasion and activates p42/44 and SAPK/JNK MAPK pathways in prostate stromal and cancer cells.Normal prostate epithelial cells were not responsive to saposin C treatment in the above studies.Conclusion:Saposin C functions as a multipotential modulator of diverse biological activities in prostate cancer and stromal cells.These results strongly suggest that saposin C functions as a potent growth factor for prostatic cells and may contribute to prostate carcinogenesis and/or the development of hormone-refractory prostate cancer.
出处 《Asian Journal of Andrology》 SCIE CAS CSCD 2005年第2期147-158, ,共12页 亚洲男性学杂志(英文版)
关键词 saposin C prostate cancer UPA/UPAR PROSAPOSIN INVASION growth factor SAPK/JNK MAPK MMP c-Jun saposin C prostate cancer uPA/uPAR prosaposin invasion growth factor SAPK/JNK MAPK MMP c-Jun
  • 相关文献

参考文献1

二级参考文献44

  • 1Kirby RS. Breaking bad news. Prostate Cancer Prostatic Dis 1998 l: 177-8.
  • 2Dong J-T, Issacs WB, Isaacs JT. Molecular advances in prostate cancer. Curr Opin Oncol 1997; 9: 101-7.
  • 3Pisters LL, Troncoso P, Zhau HE, Li W, von Eschenbach AC,Chung LW. c-met proto-oncogene expression in benign and malignant human prostate tissues. J Urol 1995; 154: 293-8.
  • 4Koivisto P, Kononen J, Palmberg C, Tammela T, Hyytinen E,Isola J, et al. Androgen receptor gene amplification: a possible molecular mechanism for androgen deprivation therapy failure in prostate cancer. Cancer Res 1997; 57: 314-9.
  • 5Mansson PE, Adams P, Kan M, McKeehan WL. Heparinbinding growth factor gene expression and receptor characteristics in normal rat prostate and two transplantable rat prostare tumors. Cancer Res 1989; 49: 2485-91.
  • 6Muller W J, Lee FS, Dickson C, Peters G, Pattengale P, Leder P. The int-2 gene product acts as an epithelial growth factor in transgenic mice. EMBO J 1990; 9: 907-13.
  • 7Sandgren EP, Luetteke NC, Palmiter RD, Brinster RL, Lee DC.Overexpression of TGF alpha in transgenic mice: induction of epithelial hyperplasia, pancreatic metaplasia, and carcinoma of the breast. Cell 1990; 15:1121-35.
  • 8Fiorelli G, De Bellis A, Longo A, Giannini S, Natali A, CostanfiniA, et al. Insulin-like growth factor-I receptors in human hyperplastic prostate tissue: characterization, tissue localization, and their modulation by chronic treatment with a gonadotropinreleasing hormone analog. J Clin Endocrinol Metab 1991; 72:740-6.
  • 9Story MT, Livingston B, Baeten L, Swartz S J, Jacobs SC,Begun FP, et al. Cultured human prostate-derived fibroblasts produce a factor that stimulates their growth with properties indistinguishable from basic fibroblast growth factor. Prostate 1989; 15: 355-65.
  • 10Wilding G, Zugmeier G, Knabbe C, Flanders K, Gelmann E. Differential effects of transforming growth factor beta on human prostate cancer cells in vitro. Mol Cell Endocrinol 1989; 62: 79-87.

共引文献5

同被引文献7

引证文献7

二级引证文献8

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部